Argent Biopharma Ltd RGT
News
Trading Information
- Previous Close Price
- A$0.03
- Day Range
- A$0.03–0.03
- 52-Week Range
- A$0.03–0.11
- Bid/Ask
- A$0.03 / A$0.04
- Shares Outstanding
- 116.61M
- Market Cap
- A$3.27M
- Volume/Avg
- 168,685 / 679,027
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 16.14
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Argent Biopharma Ltd is a revenue-generating, clinical-stage biopharmaceutical company focused on the development and commercialization of nano-engineered therapeutics targeting neurological and immunemediated disorders. Its assets, CannEpil and CimetrA, are for drug-resistant epilepsy and inflammatory conditions, respectively. The company leverages proprietary nano-delivery technologies designed to optimize bioavailability and tissue penetration, including across the blood-brain barrier and pulmonary interfaces. The company operates in a single segment. Geographically, it operates in Malta, Slovenia, UK, and Australia, with the majority of revenue deriving from Slovenia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.argentbiopharma.com
Valuation
|
Metric
|
RGT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 16.14 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RGT
|
|---|---|
Quick Ratio | 0.19 |
Current Ratio | 0.21 |
Interest Coverage | — |
Quick Ratio
RGT
Profitability
|
Metric
|
RGT
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
RGT
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|<HP#>!j | LOCK|KjFbl | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|%%<$&Y<F | LOCK|$ZpRS | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|X@$kg#@ | LOCK|kGX | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|k#>&#l> | LOCK|gF | $29B | |||
| Viatris Inc
VTRS
| LOCK|Kxc>!Sv | LOCK|%S | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|!Lz | LOCK|h^H | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|cW#<FR^ | LOCK|Sf | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|%T$Vz>^ | LOCK|#>z | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|rT>M?Lt | LOCK|%T^ty | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|!S%%QRD | LOCK|kb | $2B |
United States